# Functionalized Multi-Walled Carbon Nanotube-Based Aptasensors for Diclofenac Detection

Yi Zou, Sophie Griveau, Armelle Ringuedé, Féthi Bedioui, Cyrille Richard,

Cyrine Slim

► To cite this version:

Yi Zou, Sophie Griveau, Armelle Ringuedé, Féthi Bedioui, Cyrille Richard, et al., Functionalized Multi-Walled Carbon Nanotube-Based Aptasensors for Diclofenac Detection. Frontiers in Chemistry, 2022, 9, pp.812909. 10.3389/fchem.2021.812909. hal-03875281

HAL Id: hal-03875281

https://hal.science/hal-03875281

Submitted on 28 Nov 2022

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

Check for
updates

# Functionalized Multi-Walled Carbon Nanotube-Based Aptasensors for Diclofenac Detection

Yi Zou<fnref n="1" />, Sophie Griveau<fnref n="1" />, Armelle Ringuedé<fnref n="2" />, Fethi Bedioui<fnref n="1" />, Cyrille Richard<fnref n="3" /> and Cyrine Slim<fnref n="1" />*

Driven by the increasing concern about the risk of diclofenac (DCF) residues as water pollutants in the aqueous environment and the growing need for its trace determination, a simple but sensitive electrochemical aptasensor for the trace detection of DCF was developed. To construct the aptasensor, the amine-terminated DCF aptamer was covalently immobilized on the surface of the carboxylic acid-functionalized multi-walled carbon nanotube (f-MWCNT)-modified glassy carbon electrode (GCE) through EDC/NHS chemistry. The f-MWCNTs provide a reliable matrix for aptamer immobilization with high grafting density, while the aptamer serves as a biorecognition probe for DCF. The obtained aptasensor was incubated with DCF solutions at different concentrations and was then investigated by electrochemical impedance spectroscopy (EIS). It displays two linear ranges of concentration for DCF detection, from 250 fM to 1pM and from 1 pM to 500 nM with an extremely low detection limit of 162 fM. Also, the developed biosensor shows great reproducibility, acceptable stability, and reliable selectivity. Therefore, it offers a simple but effective aptasensor construction strategy for trace detection of DCF and is anticipated to show great potential for environmental applications.

**Keywords:** electrochemical aptasensor, aptamer, functionalized multi-walled carbon nanotubes, diclofenac, impedimetric detection

## OPEN ACCESS

**Edited by:**

Vasko Jovanovski,
National Institute of Chemistry,
Slovenia

**Reviewed by:**

Masoumeh Ghalkhani,
Shahid Rajaee Teacher Training
University, Iran
Pramod K. Kalambate,
Chulalongkorn University, Thailand

**\*Correspondence:**

Cyrine Slim

cyrine.slim@chimieparistech.psl.eu

**Specialty section:**

This article was submitted to
Analytical Chemistry,
a section of the journal
Frontiers in Chemistry

**Received:** 10 November 2021

**Accepted:** 23 December 2021

**Published:** 24 January 2022

**Citation:**

Zou Y, Griveau S, Ringuedé A, Bedioui F, Richard C and Slim C (2022) Functionalized Multi-Walled Carbon Nanotube-Based Aptasensors for Diclofenac Detection. *Front. Chem.* 9:812909.
doi: 10.3389/fchem.2021.812909

## INTRODUCTION

Diclofenac (DCF), or 2-(2-(2, 6-dichlorophenylamino) phenyl) acetic acid, is one of the most commonly used non-steroidal anti-inflammatory drugs (NSAID) with great analgesic, antipyretic, and anti-inflammatory properties (Gan, 2010; Altman et al., 2015). DCF has been extensively employed to treat musculoskeletal injuries, arthritis, and post-trauma inflammation (Cannon et al., 2006; Gorissen et al., 2012). Sold under the brand name Voltaren®, among others, DCF is prescribed as oral tablets or a topical gel frequently for rheumatic complaints, acute joint inflammation, and mild to moderate pain. Studies reported that only 6–7% of the topical gel is absorbed, while the rest is washed off the skin or attaches to clothing (Vieno and Sillanpää., 2014). This is significant regarding environmental contamination because a large percentage of the topically applied DCL will end up washed down household drains, ultimately ending up in the wastewater treatment plant (WWTP) influent. The environmental effects of DCL are harmful (Cleuvers, 2004; Haap et al., 2008), and it was included in the watch list of substances in the European Union that requires its environmental monitoring (Richardson and Ternes, 2011). It has been reported that DCF can harm lots of aquatic

<footnote n="1">¹Institute of Chemistry for Life and Health Sciences (i-CLeHS), Chimie ParisTech, PSL Research University, CNRS, Paris, France,</footnote>

<footnote n="2">²Institut de Recherche de Chimie de Paris (IRCP), PSL Research University, CNRS, Chimie ParisTech, Paris, France,</footnote>

<footnote n="3">³Université de Paris, CNRS, INSERM, UTCBS, Paris, France</footnote>
environment species at a low concentration around 3 nM (Vieno and Sillanpää, 2014). Due to its extensive use, poor degradation, and incomplete elimination during wastewater treatment (Lindqvist et al., 2005; Bonnefille et al., 2018; Grandclément et al., 2020), DCF is often found at various concentration levels in many freshwater ecosystems worldwide (Acuña et al., 2015). Also, its ecotoxicity is due to continuous accumulation in the aquatic environment, and little is known on the long-term effects (Fent et al., 2006; Ort et al., 2009). Considering its negative impact on the organisms and environment, it is crucial and urgent to establish an effective method to quantify DCF in the aquatic environment at trace amounts not only to assess its environmental risk but also to verify and improve the wastewater treatment processes.

Plenty of methods have been reported for DCF quantification in biological fluids and the environment. They are mainly based on conventional methods including high-performance liquid chromatography (HPLC) (Arcelloni et al., 2001), high-performance liquid chromatography-mass spectrometry (HPLC-MS) (Abdel-Hamid et al., 2001), spectrofluorometry (Castillo and Bruzzone, 2006), gas chromatography (Sioufi et al., 1991), thin layer chromatography (Thongchai et al., 2006), and capillary zone electrophoresis (CZE) (Jin and Zhang, 2000). Although these analytic methods are robust, they require a complicated preparation of analytical samples, skillful technicians, the use of organic solvents, and expensive apparatus. In the past few decades, the interests for DCF quantification have been switched to the electrochemical methods owing to their high sensitivity, fast response, low limit of detection (LOD), high dynamic range, user-friendly operation, lower cost, and good portability. Many groups have developed innovative sensors and biosensors for sensitive detection of DCF in various samples using the electrochemical methods (Boumya et al., 2021; Kalambate et al., 2021) such as amperometry (Shalauddin et al., 2019; Slim et al., 2019; Rohani et al., 2021), potentiometry (Lenik, 2014; Elbalkiny et al., 2019), and impedimetric methods (Derikvand et al., 2016; Kassahun et al., 2020).

Carbon nanotubes (CNTs) are nanomaterials with broad applications that are produced on a large scale. It can offer unique properties, such as high surface-to-volume ratio, strong adsorptive ability, high electrical conductivity, and chemical stability (Wang, 2005; Merkoçi, 2006). Specific forms of CNTs, for example, multi-walled carbon nanotubes (MWCNTs) are highly conductive which have been increasingly employed in the construction of electrochemical sensors for signal amplification (Carrara et al., 2014; Power et al., 2018). Besides, it also can be the base matrix for the immobilization of biomolecules to fabricate biosensors. Bioreceptors, such as aptamers and antibodies, can provide the biosensor with high selectivity since they give the particular affinity for the specific targets. Aptamers, mostly artificial single-stranded DNA molecules, are capable of binding targets with a selective and high affinity. In comparison to traditional antibodies, aptamers show advantages such as low cost, thermal stability, easy functionalization, and long shelf time (Song et al., 2008).

Recent studies (Jarczewska et al., 2016; Grabowska et al., 2018; Li et al., 2019) showed that there is an increasing interest to develop electrochemical aptasensors for target detection.

In this work, we have integrated the advantages of the MWCNTs to be the matrix providing high grafting density of aptamers, specific biorecognition properties of the aptamers, and electrochemical methods for selective and sensitive quantification of DCF. To fabricate the aptasensor, the glassy carbon electrode (GCE) was first modified with carboxylic acid-functionalized multi-walled carbon nanotubes (f-MWCNTs), followed by the covalent immobilization of amine-terminated DCF aptamer through the formation of amide bonds *via* two-stage EDC/ NHS chemistry. The aptamer covalent immobilization was confirmed by ATR-FTIR. Upon the addition of DCF as the target, the aptamer binds the DCF forming the DCF-aptamer complex on the surface of the aptasensor which can directly change the charge transfer resistance ($R_{ct}$) characterized by EIS. In addition, other important performances, such as reproducibility, stability, and selectivity were also evaluated electrochemically.

## EXPERIMENT

### Materials and Reagents

Potassium ferrocyanide [$K_4Fe(CN)_6$], 2-[(2,6-Dichlorophenyl) amino] benzeneacetic acid sodium salt (DCF), N-hydroxysuccinimide (NHS), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), and phosphate buffered saline (PBS) were purchased from Sigma-Aldrich and were used as received. The aptamer used for sensing [amine-terminated DCF aptamer (75 bases)] has the sequence of 5'-/5AmMC6/ATA CCA GCT TAT TCA ATT GCA ACG TGG CGG TCA GTC AGC GGG TGG TGG GTT CGG TCC AGA TAG TAA GTG CAA TCT-3' and was purchased from Integrated DNA Technologies. The DCF aptamer was received as a lyophilized powder, then dissolved in 7.5 ml phosphate buffer solution (0.1 M, pH = 7.4) to make a stock solution of 100 µM DCF aptamer and stored in a freezer at -20 °C until use. Distilled water (18.2 MΩ cm) purified using a Purelab flex system (Elga Water, Veolia, France) was used throughout the experiments for aqueous solution preparation. For the detection of DCF in the PBS (0.1 M, pH = 7.4), a stock solution of 1 mM DCF was weekly prepared and diluted to different concentrations.

### Instruments

All electrochemical measurements including cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) were carried out using a Bio-Logic instrument (Bio-Logic SP-300, driven by EC-Lab software, France). A conventional three-electrode system was used, consisting of a bare or modified glassy carbon electrode (GCE) as the working electrode (3 mm in diameter), an Ag/AgCl electrode as the reference electrode, and a platinum wire as the counter electrode. The surface of the aptasensor was characterized by ATR-FTIR using Agilent Cary 660 to confirm the formation of amide bonds.
<figure><img src="image_3.png" /><figcaption>**FIGURE 1** | Schematic view of the DCF electrochemical biosensor development.</figcaption></figure>

## Synthesis of f-MWCNTs

The preparation of MWCNTs/GCE from pristine MWCNT was performed, as described in the study (Karthik et al., 2017), with minor modifications. The pristine MWCNTs (100 mg) were dispersed in 40 mL of a mixture of nitric acid and sulfuric acid (1:3) and heated at 90°C for 4 h. Then, the pristine f-MWCNTs dispersion was diluted to 1 L with mQ water. After this, the dispersion was centrifuged at 4600 rpm for 10 min, and the supernatant was washed until the pH becomes neutral. Suspensions of f-MWCNTs at 5.5 mg/mL are obtained and stored at 4°C in distilled water until use.

## Construction of the Biosensor

The process of the aptasensor development is illustrated in **Figure 1**. Prior to the modification, GCE was polished carefully on grit sandpapers with different grain sizes (1200–2400 and finally 4000) and washed with ultrapure water to remove adherent substances and reached a mirror-like surface. A 5 µL of 1 mg mL⁻¹ f-MWCNT suspension was then drop-casted onto the surface of GCE and left to dry in an oven at 70°C for 1 h. The obtained modified electrode is denoted as f-MWCNTs/GCE. After this, the covalent immobilization of the amine-terminated DCF aptamer on the resulting f-MWCNTs/GCE was performed by using a two-stage EDC/NHS chemistry. For this purpose, 10 µL of 50 mM EDC and 100 mM NHS solution in PBS (0.1 M, pH = 6.2) were used to activate the carboxyl groups of f-MWCNTs. After drying in ambient air for 1 h, the obtained activated surface was then incubated with 10 µL DCF aptamer at 10 µM in PBS (0.1 M, pH = 7.4) for 1 h at 25°C (Nazari et al., 2019). Before grafting, the aptamer solution was heated at 75°C for 10 min to denature the single strand allowing for its folding into a complex shape for DCF capture. Once the immobilization of the aptamer was performed, the electrode was washed with PBS to remove the unreacted EDC, NHS, and non-grafted DCF aptamer. Then, the obtained modified electrode was denoted as Aptamer/EDC-NHS/f-MWCNTs/GCE.

To achieve the DCF detection, this aptasensor (Aptamer/EDC-NHS/f-MWCNTs/GCE) was incubated with different

<figure><img src="image_4.png" /><figcaption>**FIGURE 2** | ATR-FTIR spectra of EDC-NHS/f-MWCNTs/GCE (black) and the Aptamer/EDC-NHS/f-MWCNTs/GCE (red) surface.</figcaption></figure>

DCF concentrations (in 200 µL of PBS 0.1 M, pH 7.4) for 1 h at room temperature and then washed with PBS to eliminate the unreacted DCF.

## Electrochemical Measurements

Electrochemical measurements including cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) techniques were carried out to characterize the modified electrodes at the different steps of the aptasensor construction.

CV was performed in the presence of 5 mM K₄[Fe(CN)₆] in PBS (0.1 M, pH = 7.4) by sweeping the potential between -0.4 V and +1.1 V (vs. Ag/AgCl) at a scan rate of 50 mV/s.

EIS measurements were performed in K₄[Fe(CN)₆] 5 mM in PBS at the open circuit potential (0.16 V) with an oscillation
<figure><img src="image_5.png" /><figcaption>**FIGURE 3** | Cyclic voltammograms of the electrode in different stages of the aptasensor construction at 50 mV/s in a solution of PBS (0.1 M, pH = 7.4) containing 5 mM K₄[Fe(CN)₆]: bare GCE (red), f-MWCNTs/GCE (blue), Aptamer/EDC-NHS/f-MWCNTs/GCE (black), and DCF/Aptamer/EDC-NHS/f-MWCNTs/GCE (green).</figcaption></figure>

potential of 10 mV over the frequency range of 100 kHz to 10 mHz.

# RESULTS AND DISCUSSION

## ATR-FTIR Characterization

ATR-FTIR spectroscopy measurements of the EDC-NHS/
f-MWCNTs/GCE and Aptamer/EDC-NHS/f-MWCNTs/GCE

aptasensor were carried out and presented in **Figure 2**. For the EDC-NHS/f-MWCNTs/GCE (**Figure 2** black curve), the appearance of the peak at 1704 cm⁻¹ can be ascribed to the presence of a C=O stretching mode of unreacted carboxylic groups of f-MWCNTs (Pilehvar et al., 2014). Characteristic bands appeared around 1637 cm⁻¹ and 1562 cm⁻¹ are representative of the COO-NHS ester moiety. After aptamer immobilization, the spectrum of Aptamer/EDC-NHS/f-MWCNTs/GCE (**Figure 2** red curve) exhibits a decrease in the peak of the unreacted COOH and COO-NHS ester, while two additional peaks with small intensity appear around 1608 cm⁻¹ and 1533 cm⁻¹, attributed to the carbonyl stretch (amide II band) and NH bending (amide I band), confirming the successful DCF aptamer immobilization *via* the formation of the amide bond (add references). In addition, two obvious bands around 1220 cm⁻¹ and 1080 cm⁻¹ are representative of the C-O bond, which are not considered in this work.

## Electrochemical Characterization

The different steps of the aptasensor construction were also analyzed by cyclic voltammetry (CV). **Figure 3** shows the voltammograms of K₄Fe(CN)₆ of the carbon electrode at different steps of the aptasensor preparation: bare GCE, f-MWCNT-coated GCE (f-MWCNTs/GCE), Aptamer/EDC-NHS/f-MWCNTs/GCE, and DCF/Aptamer/EDC-NHS/f-MWCNTs/GCE.

It is obvious that modification of GCE with f-MWCNTs leads to an increase in the peak current density of the redox probe (Figure 3 blue curve). This result is due to the special electronic properties of the f-MWCNT material that can significantly accelerate the electron transfer rate *via* its large specific surface area and high conductivity. After the DCF aptamer was covalently immobilized onto f-MWCNT-coated GCE, a significant decrease in the redox peak current density and increased separation potential (Figure 3, black curve, ΔEp

<figure><img src="image_6.png" /><figcaption>**FIGURE 4** | Nyquist plots of: bare GCE (black), f-MWCNTs/GCE (red), Aptamer/EDC-NHS/f-MWCNTs/GCE (blue), and DCF/Aptamer/EDC-NHS/f-MWCNTs/GCE (green) electrodes obtained in 0.1 M PBS (pH = 7.4) containing 5 mM K₄[Fe(CN)₆] in the frequency range of 100 kHz to 10 mHz. DCF/Aptamer/EDC-NHS/f-MWCNTs/GCE corresponds to the behavior of the aptasensor after its incubation in a solution containing 1 µM DCF for 1 h at ambient temperature.</figcaption></figure>
<figure><img src="image_7.png" /><figcaption>**FIGURE 5** | Nyquist plots obtained in 0.1 M PBS containing 5 mM $K_4[Fe(CN)_6]$ after incubation of the aptasensor with different concentrations of DCF solutions from 10 fM to 500 nM in the frequency range of 100 kHz to 10 mHz.</figcaption></figure>

0.33 V) compared to f-MWCNTs/GCE was observed (Figure 3, blue curve, $\Delta$Ep = 0.08 V). This is understandable because non-conductive EDC, NHS, and DCF-aptamer serve as an insulating barrier which impairs the interfacial charge transfer process. After incubating the biosensor with 200 µL of the DCF aptamer at 1 µM concentration for 1 h, the peak current density decreases continually (Figure 3, green curve), indicating that the interaction between the DCF and DCF aptamer forming the DCF/DCF aptamer complex occurs, increasing the resistance of the charge transfer process on the surface of the biosensor.

<figure><img src="image_8.png" /><figcaption>**FIGURE 6** | Nyquist plots obtained in 0.1 M PBS containing 5 mM $K_4[Fe(CN)_6]$ after incubation of the EDC-NHS/f-MWCNTs/GCE with 1, 50, and 500 nM concentration of DCF in the frequency range of 100 kHz to 10 mHz.</figcaption></figure>

**Figure 4** shows the Nyquist diagrams obtained in each stepwise fabrication of the aptasensor. The Nyquist plots of the electrodes include a semicircle at the highest frequency range and a linear part at the lowest frequencies. The semicircle part represents the charge transfer resistance ($R_{ct}$) at the electrode surface, while the linear part related to diffusion processes is not affected by the aptasensor fabrication. In this work, a classical Randles equivalent circuit was used for calibration measurements (Figure 4, upper left corner). This equivalent circuit includes $R_s$, $C_{dl}$, $R_{ct}$, and $Z_w$. The $R_s$ element is related to the electrolyte resistance, while the $C_{dl}$ element represents the capacitor derived from the electrode interface double layer. The $R_{ct}$ element is correlated with the charge transfer resistance derived from the electrode surfaces. These parameters are affected by the variations occurring on the electrode surface. The $Z_w$ element is a specialized electrochemical element representing the diffusion processes which is not considered in the following analysis.

The Nyquist plot of bare GCE exhibits a small semicircle (Figure 4, black curve), indicating a small charge transfer resistance ($R_{ct}$ = 1220 Ω) and a clean GCE surface. After GCE surface modification with f-MWCNTs (Figure 4, red curve), the $R_{ct}$ value decreases in comparison with that obtained for bare GCE ($R_{ct}$ = 865 Ω), depicting an enhanced conductivity at the electrode-electrolyte interface. When the DCF aptamer is linked on the f-MWCNTs/GCE surface, the charge transfer resistance increases ($R_{ct}$ = 8160 Ω) due to the formation of a non-conductive layer prohibiting the charge transfer between the redox probe and the surface of the aptasensor (Figure 4, blue curve). The $R_{ct}$ value is further enlarged ($R_{ct}$ = 12,390 Ω) (Figure 4, green curve) when the aptasensor is incubated in a solution containing 1 µM DCF, suggesting the formation of the DCF/DCF aptamer complex on the electrode surface that
<figure><img src="image_9.png" /><figcaption>**FIGURE 7** | Calibration curve using R<sub>ct</sub> vs. Log DCF concentration. Inset: LOD determination.</figcaption></figure>

essentially hinders the electron transfer reaction of the probe redox. The results obtained from EIS were in good agreement with the results from CV. It is desirable to note that the aptasensor exhibits a great change in the impedimetric signal after the DCF capture.

## Target Detection and Calibration Curve for DCF

The detection of DCF was carried out by incubating the aptamer-modified electrode with DCF solutions at different

concentrations, from 5.0 $10^{-17}$ to $10^{-14}$ M for 1 h. The performances of the aptasensor were investigated by recording the EIS responses in 0.1 M PBS containing 5 mM $K_4[Fe(CN)_6]$ solution (Figure 5).

The inset of Figure 5 exhibits the Randles equivalent circuit used to fit EIS analysis. As shown, it is clearly noted that the $R_{ct}$ value increases with the increasing concentration of DCF. This can be attributed to the change in the spatial conformation of the aptamer in contact with DCF. With the increase of concentration of DCF, more formation of the DCF/DCF aptamer complex results in a gradual increase of the inhibition of the electron transfer onto the aptasensor surface.

Blank controls were also performed by incubating EDC-NHS/ f-MWCNTs/GCE (without aptamer attachment) with different concentrations (1, 50, and 500 nM) of the DCF solution, as illustrated in Figure 6. In the absence of the DCF aptamer, whatever the concentration of DCF, the value of $R_{ct}$ almost keeps constant. This result confirms that the change of $R_{ct}$ for DCF/Aptamer/EDC-NHS/f-MWCNTs/GCE is due to the DCF aptamer instead of other materials or physical adsorption of DCF on the surface of modified GCE. This can also prove indirectly the successful DCF aptamer immobilization on the f-MWCNT/GCE surface.

A calibration curve was then deduced from the EIS data of Figure 5. Figure 7 shows the variations of the charge transfer resistance with DCF concentrations. Two regions are observed where the $R_{ct}$ increases linearly with the Log(DCF concentration): from 250 fM to 1 pM and from 1pM to 500 nM.

The regression equation is $R_{ct} = 1589 \log [DCF] + 29444$ with a correlation coefficient ($R^2$) of 0.9959 for low concentrations from 250 fM to 1 pM and $R_{ct} = 153 \log [DCF] + 12132$ with $R^2 =$

<figure><img src="image_10.png" /><figcaption>**FIGURE 8** | Charge transfer resistance (A) and relative standard deviation (B) at different steps of the aptasensor construction in PBS (0.1 M, pH = 7.4) containing 5 mM $K_4[Fe(CN)_6]$.</figcaption></figure>
<figure><img src="image_11.png" /><figcaption>**FIGURE 9** | Bar chart of the R<sub>ct</sub> changes (ΔR<sub>ct</sub> = R<sub>ct</sub> (analyte/apatasensor) – R<sub>ct</sub> (aptasensor)) of DCF and interferents.</figcaption></figure>

0.8564 for larger concentrations from 1 pM to 500 nM. The detection limit (LOD) was determined from the intersection between the linear part and the non-sensitive linear region (below 250 fM), as shown in the inset of **Figure 7**. The LOD was calculated to be 162 fM.

## Reproducibility and Stability of the Aptasensor

Once the response of the aptasensor to DCF was demonstrated, the reproducibility and the stability merits of the protocol developed were also evaluated.

Four aptasensors were fabricated; then, R<sub>ct</sub> values with their relative standard deviations (RSD) were recorded in each step of the aptasensor construction using EIS in 0.1 M PBS containing 5 mM K<sub>4</sub>[Fe(CN)<sub>6</sub>] (Figure 8A). After the fabricated aptasensors were incubated in 500 nM DCF solutions, the RSD of R<sub>ct</sub> was evaluated to be 4.6%, indicating the reliable reproducibility of the aptasensor (Figure 8B). The variations can be explained by the

several uncontrolled factors that can affect the impedimetric results as the electrodes are handmade.

## Interference Studies

The selectivity of the developed aptasensor was investigated by the EIS signal. The effect of two interferents, paracetamol and β-Estradiol, were studied by incubating the developed aptasensors in 1 µM of each interfering substance in 0.1 M PBS at pH 7.4. These two interferents are phenolic compounds with a similar structure as DCF. **Figure 9** shows the ΔR<sub>ct</sub> (difference between the R<sub>ct</sub> value before and after treatment with the analytes) of DCF and two interferents. The bar chart of the ΔR<sub>ct</sub> for interfering substances shows small values in comparison with the DCF as the original target. The ΔR<sub>ct</sub> value for paracetamol is higher than β-Estradiol which could be due to its greater physical adsorption on the surface of the biosensor. However, both ΔR<sub>ct</sub> values for the interferents are lower than that obtained for the target diclofenac. These satisfactory results prove that the newly developed biosensor has good selectivity for distinguishing DCF from other interferents.

## Comparative Data

Up to now, only a few reported electrochemical aptasensors have been developed for DCF detection, as summarized in **Table 1**. Electrochemical methods include EIS and differential pulse voltammetry (DPV). By adding the DCF aptamer as the biorecognition element, most of these electrochemical biosensors achieved the selective detection of DCF at the nanomolar or picomolar concentration level. The lowest LOD reached with the reported DCF biosensor is 3.4 fM (Azadbakht and Beirnvand, 2017). Compared with the previously reported electrochemical aptasensors for the DCF determination, the aptasensor developed in this work has easier construction steps and an outstanding LOD for DCF determination.

## CONCLUSION

In this work, a novel electrochemical aptasensor for the DCF determination at trace concentration was successfully

<table><caption>**TABLE 1** | Comparison between performances of the reported electrochemical aptasensors and related techniques for DCF Detection.</caption><thead><tr><td>Working electrode</td><td>Technique</td><td>Linearity</td><td>LOD (nM)</td><td>References</td></tr></thead><tbody><tr><td>DCF aptamer, gold NPs (AuNPs), and graphene-doped CdS (GR-CdS) modified Au electrode (Aptamer/GR-CdS/Au)</td><td>EIS</td><td>1–150 nM</td><td>0.78</td><td>Okoth et al. (2018)</td></tr><tr><td>DCF aptamer modified on the surface of the glassy carbon electrode (Aptamer/ AHA/GCE)</td><td>EIS</td><td>0–5µM; 0.001–1 mM</td><td>270</td><td>Kashefi-Kheyrabadi and Mehrgardi, (2012)</td></tr><tr><td>DCF aptamer, acid-oxidized carbon nanotubes (CNT), graphene oxide (GO), and Fe<sub>3</sub>O<sub>4</sub> nanomaterials modified GCE (Aptamer/CNT/GO/Fe<sub>3</sub>O<sub>4</sub>/GCE)</td><td>DPV</td><td>100–1300 pM</td><td>0.033</td><td>Azadbakht and Derikvandi, (2017)</td></tr><tr><td>Fe<sub>3</sub>O<sub>4</sub>/AuNP, CNT nanocomposite, amine-terminated DNA sequence (ssDNA1), and DCF-aptamer (ssDNA2) modified GCE (Aptamer/Fe<sub>3</sub>O<sub>4</sub>/AuNP/CNT/GCE)</td><td>DPV</td><td>0.01–1pM; 10–1300 pM</td><td>3.4 × 10<sup>-6</sup></td><td>Azadbakht and Beirnvand, (2017)</td></tr><tr><td>DCF aptamer immobilized on the surface of the hydrogel matrix-modified gold electrode (aptamer/hydrogel/SAM/Au)</td><td>EIS</td><td>30 pM to 1 µM</td><td>0.02</td><td>Kassahun et al. (2020)</td></tr><tr><td>DCF aptamer and f-MWCNTs modified GCE (aptamer/EDC-NHS/ f-MWCNTs/GCE)</td><td>EIS</td><td>0.25–1 pM; 1 pM to 500 nM</td><td>1.62 × 10<sup>-4</sup></td><td>This work</td></tr></tbody></table>
fabricated. The f-MWCNT nanocomposite and DCF aptamer
were attached on the surface of GCE through the drop casting,
and covalent amide bonds formed by the carboxylic acid
groups on the f-MWCNTs and the amino groups from the
DCF aptamer. Through the EIS technique, the addition of DCF
shows a change in Rct with the logarithm of DCF
concentrations. The densely populated aptamers and the
properties to selectively bind the specific target lead to
superior properties of the fabricated aptasensor. The
obtained aptasensor showed two linear ranges of
concentration for DCF detection, from 250 fM to 1pM and
from 1 pM to 500 nM with an extremely low detection limit of
162 fM. The developed aptasensor has a reliable
reproducibility, stability, and the effect of interfering species
on the biosensor is negligible. Its construction is based on a
simple design, without complex multi-modification strategies.
The modification is achieved with a single nanomaterial easy to
deposit and does not require long and complicated steps
compared to other biosensors which surface modification
combines the use of a mixture of several nanomaterials.
Also, the choice of carbon as the electrode material
represents several advantages such as the cheapness of the
material and the easier cleaning and activation steps required
for gold electrodes. The proposed strategy could also be

REFERENCES

Abdel-Hamid, M. E., Novotny, L., and Hamza, H. (2001). Determination of Diclofenac Sodium, Flufenamic Acid, Indomethacin and Ketoprofen by LC-APCI-MS. *J. Pharm. Biomed. Anal.* **24** (4), 587-594. doi:10.1016/s0731-7085(00)00444-1

Acuña, V., Ginebreda, A., Mor, J. R., Petrovic, M., Sabater, S., Sumpter, J., et al. (2015). Balancing the Health Benefits and Environmental Risks of Pharmaceuticals: Diclofenac as an Example. *Environ. Int.* **85**, 327–333. doi:10.1016/j.envint.2015.09.023

Altman, R., Bosch, B., Brune, K., Patrignani, P., and Young, C. (2015). Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology. *Drugs* **75** (8), 859–877. doi:10.1007/s40265-015-0392-z

Arcelloni, C., Lanzi, R., Pedercini, S., Molteni, G., Fermo, I., Pontiroli, A., et al. (2001). High-performance Liquid Chromatographic Determination of Diclofenac in Human Plasma after Solid-phase Extraction. *J. Chromatogr. B Biomed. Sci. Appl.* **763** (1), 195-200. doi:10.1016/S0378-4347(01)00383-8

Azadbakht, A., and Beirnvand, S. (2017). Voltammetric Aptamer-Based Switch Probes for Sensing Diclofenac Using a Glassy Carbon Electrode Modified with a Composite Prepared from Gold Nanoparticles, Carbon Nanotubes and Amino-Functionalized Fe3O4 Nanoparticles. *Microchim Acta* **184**, 2825-2835. doi:10.1007/s00604-017-2285-1

Azadbakht, A., and Derikvandi, Z. (2017). Aptamer-based Sensor for Diclofenac Quantification Using Carbon Nanotubes and Graphene Oxide Decorated with Magnetic Nanomaterials. *J. Iran Chem. Soc.* **15**, 595–606. doi:10.1007/s13738-017-1259-x

Bonnefille, B., Gomez, E., Courant, F., Escande, A., and Fenet, H. (2018). Diclofenac in the marine environment: A Review of its Occurrence and Effects. *Mar. Pollut. Bull.* **131**, 496–506. doi:10.1016/j.marpolbul.2018.04.053

Boumya, W., Taoufik, N., Achak, M., Bessbousse, H., Elhalil, A., and Barka, N. (2021). Electrochemical Sensors and Biosensors for the Determination of Diclofenac in Pharmaceutical, Biological and Water Samples. *Talanta Open* **3**, 100026–1000039. doi:10.1016/j.talo.2020.100026

transferred to miniaturized devices or integrated into
microfluidic systems for example.

DATA AVAILABILITY STATEMENT

The raw data supporting the conclusion of this article will be
made available by the authors, without undue reservation.

AUTHOR CONTRIBUTIONS

All authors listed have made a substantial, direct, and
intellectual contribution to the work and approved it for
publication.

ACKNOWLEDGMENTS

We would likewise extend our gratitude to Dr Grégory
Lefèvre from "Institut de Recherche de Chimie Paris"
(IRCP) Chimie ParisTech for his help on the ATR-FTIR
measurements.

Cannon, C. P., Curtis, S. P., FitzGerald, G. A., Krum, H., Kaur, A., Bolognese, J. A., et al. (2006). Cardiovascular Outcomes with Etoricoxib and Diclofenac in Patients with Osteoarthritis and Rheumatoid Arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-Term (MEDAL) Programme: a Randomised Comparison. *The Lancet* **368** (9549), 1771–1781. doi:10.1016/S0140-6736(06)69666-9

Carrara, S., Baj-Rossi, C., Boero, C., and De Micheli, G. (2014). Do Carbon Nanotubes Contribute to Electrochemical Biosensing? *Electrochimica Acta* **128**, 102–112. doi:10.1016/j.electacta.2013.12.123

Castillo, M. A., and Bruzzone, L. (2006). Indirect Fluorometric Determination of Diclofenac Sodium. *Anal. Sci.* **22** (3), 431–433. doi:10.2116/analsci.22.431

Cleuvers, M. (2004). Mixture Toxicity of the Anti-inflammatory Drugs Diclofenac, Ibuprofen, Naproxen, and Acetylsalicylic Acid. *Ecotoxicology Environ. Saf.* **59** (3), 309–315. doi:10.1016/S0147-6513(03)00141-6

Derikvand, H., Roushani, M., Abbasi, A. R., Derikvand, Z., and Azadbakht, A. (2016). Design of Folding-Based Impedimetric Aptasensor for Determination of the Nonsteroidal Anti-inflammatory Drug. *Anal. Biochem.* **513**, 77–86. doi:10.1016/j.ab.2016.06.013

Elbalkiny, H. T., Yehia, A. M., Riad, S. a. M., and Elsaharty, Y. S. (2019). Potentiometric Diclofenac Detection in Wastewater Using Functionalized Nanoparticles. *Microchemical J.* **145**, 90–95. doi:10.1016/j.microc.2018.10.017

Fent, K., Weston, A., and Caminada, D. (2006). Ecotoxicology of Human Pharmaceuticals. *Aquat. Toxicol.* **76** (2), 122–159. doi:10.1016/j.aquatox.2005.09.009

Gan, T. J. (2010). Diclofenac: an Update on its Mechanism of Action and Safety Profile. *Curr. Med. Res. Opin.* **26** (7), 1715–1731. doi:10.1185/03007995.2010.486301

Gorissen, K. J., Benning, D., Berghmans, T., Snoeijs, M. G., Sosef, M. N., Hulsewe, K. W. E., et al. (2012). Risk of Anastomotic Leakage with Non-steroidal Anti-inflammatory Drugs in Colorectal Surgery. *Br. J. Surg.* **99** (5), 721–727. doi:10.1002/bjs.8691

Grabowska, I., Sharma, N., Vasilescu, A., Iancu, M., Badea, G., Boukherroub, R., et al. (2018). Electrochemical Aptamer-Based Biosensors for the Detection of Cardiac Biomarkers. *ACS Omega* **3** (9), 12010–12018. doi:10.1021/acsomega.8b01558
Grandclément, C., Piram, A., Petit, M.-E., Seyssiecq, I., Laffont-Schwob, I., Vanot, G., et al. (2020). Biological Removal and Fate Assessment of Diclofenac Using Bacillus Subtilis and Brevibacillus Laterosporus Strains and Ecotoxicological Effects of Diclofenac and 4'-Hydroxy-Diclofenac. *J. Chem.* 2020, 1-12. doi:10.1155/2020/9789420

Haap, T., Triebskorn, R., and Köhler, H.-R. (2008). Acute Effects of Diclofenac and DMSO to Daphnia magna: Immobilisation and Hsp70-Induction. *Chemosphere* 73 (3), 353-359. doi:10.1016/j.chemosphere.2008.05.062

Jarczewska, M., Górski, Ł., and Malinowska, E. (2016). Electrochemical Aptamer-Based Biosensors as Potential Tools for Clinical Diagnostics. *Anal. Methods* 8, 3861-3877. doi:10.1039/C6AY00499G

Jin, W., and Zhang, J. (2000). Determination of Diclofenac Sodium by Capillary Zone Electrophoresis with Electrochemical Detection. *J. Chromatogr.* A 868, 101-107. doi:10.1016/S0021-9673(99)01149-8

Kalambate, P. K., Noiphung, J., Rodthongkum, N., Larpant, N., Thirabowonkitphithan, P., Rojanarata, T., et al. (2021). Nanomaterials-based Electrochemical Sensors and Biosensors for the Detection of Non-steroidal Anti-inflammatory Drugs. *Trac Trends Anal. Chem.* 143, 116403-116431. doi:10.1016/j.trac.2021.116403

Karthik, R., Sasikumar, R., Chen, S.-M., Vinoth Kumar, J., Elangovan, A., Muthuraj, V., et al. (2017). A Highly Sensitive and Selective Electrochemical Determination of Non-steroidal Prostate Anti-cancer Drug Nilutamide Based on F-MWCNT in Tablet and Human Blood Serum Sample. *J. Colloid Interf. Sci.* 487, 289-296. doi:10.1016/j.jcis.2016.10.047

Kashefi-Kheyrabadi, L., and Mehrgardi, M. A. (2012). Design and Construction of a Label Free Aptasensor for Electrochemical Detection of Sodium Diclofenac. *Biosens. Bioelectron.* 33 (1), 184-189. doi:10.1016/j.bios.2011.12.050

Kassahun, G. S., Griveau, S., Juillard, S., Champavert, J., Ringuedé, A., Bresson, B., et al. (2020). Hydrogel Matrix-Grafted Impedimetric Aptasensors for the Detection of Diclofenac. *Langmuir* 36 (4), 827-836. doi:10.1021/acs.langmuir.9b02031

Lenik, J. (2014). A New Potentiometric Electrode Incorporating Functionalized β-cyclodextrins for Diclofenac Determination. *Mater. Sci. Eng. C* 45, 109-116. doi:10.1016/j.msec.2014.08.072

Li, F., Yu, Z., Han, X., and Lai, R. Y. (2019). Electrochemical Aptamer-Based Sensors for Food and Water Analysis: A Review. *Analytica Chim. Acta* 1051, 1-23. doi:10.1016/j.aca.2018.10.058

Lindqvist, N., Tuhkanen, T., and Kronberg, L. (2005). Occurrence of Acidic Pharmaceuticals in Raw and Treated Sewages and in Receiving Waters. *Water Res.* 39 (11), 2219-2228. doi:10.1016/j.watres.2005.04.003

Merkoçi, A. (2006). Carbon Nanotubes in Analytical Sciences. *Microchim Acta* 152 (3), 157-174. doi:10.1007/s00604-005-0439-z

Nazari, M., Kashanian, S., Rafipour, R., and Omidfar, K. (2019). Biosensor Design Using an Electroactive Label-Based Aptamer to Detect Bisphenol A in Serum Samples. *J. Biosci.* 44, 105. doi:10.1007/s12038-019-9921-3

Okoth, O. K., Yan, K., Feng, J., and Zhang, J. (2018). Label-free Photoelectrochemical Aptasensing of Diclofenac Based on Gold Nanoparticles and Graphene-Doped CdS. *Sensors Actuators B: Chem.* 256, 334-341. doi:10.1016/j.snb.2017.10.089

Ort, C., Hollender, J., Schaerer, M., and Siegrist, H. (2009). Model-Based Evaluation of Reduction Strategies for Micropollutants from Wastewater Treatment Plants in Complex River Networks. *Environ. Sci. Technol.* 43 (9), 3214-3220. doi:10.1021/es802286v

Pilehvar, S., Ahmad Rather, J., Dardenne, F., Robbens, J., Blust, R., and De Wael, K. (2014). Carbon Nanotubes Based Electrochemical Aptasensing Platform for the

Detection of Hydroxylated Polychlorinated Biphenyl in Human Blood Serum. *Biosens. Bioelectron.* 54, 78-84. doi:10.1016/j.bios.2013.10.018

Power, A. C., Gorey, B., Chandra, S., and Chapman, J. (2018). Carbon Nanomaterials and Their Application to Electrochemical Sensors: a Review. *Nanotechnology Rev.* 7, 19-41. doi:10.1515/ntrev-2017-0160

Richardson, S. D., and Ternes, T. A. (2011). Water Analysis: Emerging Contaminants and Current Issues. *Anal. Chem.* 83 (12), 4614-4648. doi:10.1021/ac200915r

Rohani, T., Mohammadi, S. Z., Gholamhosein Zadeh, N., and Askari, M. B. (2021). A Novel Carbon Ceramic Electrode Modified by Fe3O4 Magnetic Nanoparticles Coated with Aptamer-Immobilized Polydopamine: An Effective Label-free Aptasensor for Sensitive Detection of Diclofenac. *Microchemical J.* 166, 106274-106281. doi:10.1016/j.microc.2021.106274

Shalauddin, M., Akhter, S., Basirun, W. J., Bagheri, S., Anuar, N. S., and Johan, M. R. (2019). Hybrid Nanocellulose/f-MWCNTs Nanocomposite for the Electrochemical Sensing of Diclofenac Sodium in Pharmaceutical Drugs and Biological Fluids. *Electrochimica Acta* 304, 323-333. doi:10.1016/j.electacta.2019.03.003

Sioufi, A., Pommier, F., and Godbillon, J. (1991). Determination of Diclofenac in Plasma and Urine by Capillary Gas Chromatography-Mass Spectrometry with Possible Simultaneous Determination of Deuterium-Labeled Diclofenac. *J. Chromatogr.* 571 (1-2), 87-100. doi:10.1016/0378-4347(91)80436-g

Slim, C., Tlili, N., Richard, C., Griveau, S., and Bedioui, F. (2019). Amperometric Detection of Diclofenac at a Nano-Structured Multi-wall Carbon Nanotubes Sensing Films. *Inorg. Chem. Commun.* 107, 107454. doi:10.1016/j.inoche.2019.107454

Song, S., Wang, L., Li, J., Fan, C., and Zhao, J. (2008). Aptamer-based Biosensors. *Trac Trends Anal. Chem.* 27 (2), 108-117. doi:10.1016/j.trac.2007.12.004

Thongchai, W., Liawruangrath, B., Thongpoon, C., and Machan, T. (2006). High Performance Thin Layer Chromatographic Method for the Determination of Diclofenac Sodium in Pharmaceutical Formulations. *Chiang Mai J. Sci.* 33 (1), 123-128.

Vieno, N., and Sillanpää, M. (2014). Fate of Diclofenac in Municipal Wastewater Treatment Plant - A Review. *Environ. Int.* 69, 28-39. doi:10.1016/j.envint.2014.03.021

Wang, J. (2005). Carbon-Nanotube Based Electrochemical Biosensors: A Review. *Electroanalysis* 17, 7-14. doi:10.1002/elan.200403113

**Conflict of Interest:** The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Publisher's Note:** All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Copyright © 2022 Zou, Griveau, Ringuedé, Bedioui, Richard and Slim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.